## HRL: Hormel Foods Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 2.7% below STRENGTH zone (3.0-6.0%); PEG 3.37 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($22.99)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 1)

**1. HRL Investor News: If You Have Suffered Losses in Hormel**
- Source: GlobeNewswire | 20251212T204708 | Bearish | Relevance: 100%
- The Rosen Law Firm is investigating potential securities claims against Hormel Foods Corporation (NYSE: HRL) after the company's stock fell due to cuts in its forecast, price pressures, and a CFO departure. Investors who purchased Hormel securities and suffered losses are encouraged to contact the law firm to join a prospective class action for compensation. The firm highlights its track record in securities class actions and derivative litigation, having recovered hundreds of millions for investors.

**2. Hormel Foods (NYSE: HRL) SKIPPY named key in Milk Bar holiday pie**
- Source: Stock Titan | 20251215T130229 | Bullish | Relevance: 100%
- Hormel Foods' SKIPPY brand has partnered with Milk Bar to reveal that SKIPPY Creamy Peanut Butter is the secret ingredient in Milk Bar's popular Chocolate Peanut Butter Crunch Pie. The pie is available at Milk Bar bakeries and nationwide online starting December 15, 2025. To celebrate, the brands also released a simple at-home recipe for Peanut Butter Crunch Bars, combining creamy peanut butter, toasted rice cereal, and a chocolate-peanut coating.

**3. Hormel (HRL) Featured in Barclays’ Forward Look at Agriculture and Protein Demand**
- Source: Insider Monkey | 20251215T094300 | Neutral | Relevance: 100%
- Barclays has outlined its forecast for the Americas agribusiness sector, highlighting mixed results for 2026, with optimism for seed companies and a neutral to positive outlook for fertilizers. Despite cutting Hormel Foods Corporation's (NYSE:HRL) price target to $31, Barclays maintained an Overweight rating on the stock. Hormel reported Q4 2025 revenue growth of 2% and is implementing restructuring efforts, including job cuts and a voluntary early retirement program, to improve profitability amidst input cost inflation.

**4. The SKIPPY® brand partners with Milk Bar® to reveal the secret ingredient behind a holiday favorite**
- Source: Hormel Foods | 20251215T090820 | Bullish | Relevance: 100%
- The SKIPPY® brand and Milk Bar® have partnered to reveal that SKIPPY® Creamy Peanut Butter is the secret ingredient in Milk Bar's iconic Chocolate Peanut Butter Crunch Pie. To celebrate, they are also releasing a new Peanut Butter Crunch Bar recipe for home bakers, offering a simple way to bring the beloved holiday flavor into kitchens. The pie is available at Milk Bar bakeries and for nationwide shipping starting December 15, 2025.

**5. 75,000 Shares in Hormel Foods Corporation $HRL Purchased by Walnut Level Capital LLC**
- Source: MarketBeat | 20251214T135006 | Somewhat-Bullish | Relevance: 100%
- Walnut Level Capital LLC recently acquired 75,000 shares of Hormel Foods Corporation ($HRL) in the second quarter, making it the firm's 14th largest position. Hormel Foods reported better-than-expected Q2 earnings per share but missed revenue estimates and expects full-year 2026 EPS between $1.43–$1.51, along with increasing its quarterly dividend. The stock currently holds a "Hold" consensus rating from analysts with an average target price of $28.29.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $30 | $31 | -3% |
| 2025-12-05 | Piper Sandler | $26 | $25 | +4% |
| 2025-12-05 | JP Morgan | $28 | $27 | +4% |
| 2025-12-05 | B of A Securiti | $26 | $25 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | main | Overweight |
| 2025-12-05 | Piper Sandler | main | Neutral |
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-12-05 | B of A Securiti | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 12 ($0.26M) |
| Sells | 7 ($0.13M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 6.8% (+2.0%)
- State Street Corpora: 5.1% (+1.0%)
- Blackrock Inc.: 4.6% (+2.2%)
- Invesco Ltd.: 2.1% (+66.5%)
- Geode Capital Manage: 1.5% (+1.7%)

### Key Risks

1. Valuation risk: PEG 3.4x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 12.5% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +4%) could attract flows.
- Momentum building: MRS_10 improving +1.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 3.37 signals overvaluation risk, limited margin of safety. Forward P/E 15.4x stretched relative to 6% growth. Balance sheet: strong liquidity (2.5x). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.2B |
| Beta | 0.33 |
| 52W Range | $21.03 - $33.12 |
| Short Interest | 5.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.37 |
| Forward P/E | 15.4 |
| Current P/E | 16.4 |
| YoY Growth | 6.3% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from 1.0% to 2.7% (+1.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.3pp (needs >3.0% for momentum thesis). MRS_5 at 2.4% confirms short-term momentum alignment. Below SMA200 (0.88x), long-term trend not supportive. OFD pattern: +MUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.66% (CS: 61) | Neutral |
| RSI_14 | 61.6 | Neutral |
| MACD Histogram | 0.11 | Bullish |
| vs SMA20 | 1.038x | Above |
| vs SMA50 | 1.040x | Above |
| vs SMA200 | 0.875x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $24.05
- **Stop Loss:** $22.99 (4.4% risk)
- **Target:** $25.11 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1132
- **Position Value:** $27,224.60
- **Portfolio %:** 27.22%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-26 (Est: $0.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.30 | $0.32 | +6.0% |
| 2025Q3 | $0.41 | $0.35 | -14.5% |
| 2025Q2 | $0.34 | $0.35 | +3.3% |
| 2025Q1 | $0.37 | $0.35 | -6.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*